首页 › 基金 › Data Collective IV GP, LLC › RXRX
Data Collective IV GP, LLC 对 RXRX 的持仓历史
RECURSION PHARMACEUTICALCLASS A · 医疗保健
Data Collective IV GP, LLC 在 Q2 2026 的 13F 申报中披露持有 RXRX(RECURSION PHARMACEUTICALCLASS A)5,941,120 股,市值约 US$21.8M,约占其申报组合的 27.76%,在其申报持仓中市值排名第 3 位。 Data Collective IV GP, LLC 最近 12 个申报季度中有 12 个季度披露了 RXRX 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
Data Collective IV GP, LLC 对 RXRX 的持仓演变
Data Collective IV GP, LLC 于 Q3 2023 首次披露 RXRX 持仓:5,941,120 股(约 US$45.4M)。 该持仓在 Q1 2024 达到峰值 5,941,120 股,市值约 US$59.2M。 在 12 次申报中,Data Collective IV GP, LLC 的持股数量始终未变。 最近一期申报(Q2 2026)显示持股 5,941,120 股、市值约 US$21.8M。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 5.94M | $45.45M | 新进 |
| Q4 2023 | 5.94M | $58.58M | 持有 |
| Q1 2024 | 5.94M | $59.23M | 持有 |
| Q2 2024 | 5.94M | $44.56M | 持有 |
| Q3 2024 | 5.94M | $39.15M | 持有 |
| Q4 2024 | 5.94M | $40.16M | 持有 |
| Q1 2025 | 5.94M | $31.43M | 持有 |
| Q2 2025 | 5.94M | $30.06M | 持有 |
| Q3 2025 | 5.94M | $28.99M | 持有 |
| Q4 2025 | 5.94M | $24.30M | 持有 |
| Q1 2026 | 5.94M | $18.24M | 持有 |
| Q2 2026 | 5.94M | $21.80M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 RXRX 与 13F 数据
RXRX(RECURSION PHARMACEUTICALCLASS A)属于医疗保健行业。我们追踪的基金中还有 28 只申报持有 RXRX,申报仓位最大的包括:方舟投资 (US$151.7M), SOFTBANK GROUP CORP. (US$50.0M), MIC Capital Management UK LLP (US$35.4M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 RXRX 的基金
- 方舟投资 41.34M 股 · $151.71M · Q2 2026
- SOFTBANK GROUP CORP. 13.64M 股 · $50.05M · Q2 2026
- MIC Capital Management UK LLP 9.64M 股 · $35.39M · Q2 2026
- DCVC Opportunity Fund II GP, LLC 3.95M 股 · $14.50M · Q2 2026
更多关于 Data Collective IV GP, LLC
常见问题
How long has Data Collective IV GP, LLC held RXRX?
Data Collective IV GP, LLC has disclosed RXRX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Data Collective IV GP, LLC's current position in RXRX?
As of Q2 2026, Data Collective IV GP, LLC holds 5.94M shares of RXRX (RECURSION PHARMACEUTICALCLASS A), valued at $21.80M, representing 27.76% of its reported portfolio and ranking #3.
Has Data Collective IV GP, LLC been buying or selling RXRX?
In the latest 13F filing (Q2 2026), Data Collective IV GP, LLC held unchanged its position in RXRX. The position peaked in Q1 2024 at 5.94M shares.
Which other funds hold RXRX?
Other major institutional holders of RXRX include 方舟投资, SOFTBANK GROUP CORP., MIC Capital Management UK LLP, among 28 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.